Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medifast (MED) Current Leases (2016 - 2025)

Medifast's Current Leases history spans 11 years, with the latest figure at $4.6 million for Q4 2025.

  • For Q4 2025, Current Leases fell 25.54% year-over-year to $4.6 million; the TTM value through Dec 2025 reached $4.6 million, down 25.54%, while the annual FY2025 figure was $4.6 million, 25.54% down from the prior year.
  • Current Leases reached $4.6 million in Q4 2025 per MED's latest filing, down from $5.5 million in the prior quarter.
  • In the past five years, Current Leases ranged from a high of $6.7 million in Q1 2022 to a low of $3.7 million in Q1 2021.
  • Average Current Leases over 5 years is $5.7 million, with a median of $5.9 million recorded in 2023.
  • Peak YoY movement for Current Leases: skyrocketed 82.5% in 2022, then dropped 25.54% in 2025.
  • A 5-year view of Current Leases shows it stood at $6.5 million in 2021, then fell by 11.45% to $5.8 million in 2022, then increased by 1.89% to $5.9 million in 2023, then rose by 5.05% to $6.2 million in 2024, then dropped by 25.54% to $4.6 million in 2025.
  • Per Business Quant, the three most recent readings for MED's Current Leases are $4.6 million (Q4 2025), $5.5 million (Q3 2025), and $5.9 million (Q2 2025).